Di Tommaso L - Search Results

1

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.

Zeng Q, Klein C, Caruso S, Maille P, Allende DS, Mínguez B, Iavarone M, Ningarhari M, Casadei-Gardini A, Pedica F, Rimini M, Perbellini R, Boulagnon-Rombi C, Heurgué A, Maggioni M, Rela M, Vij M, Baulande S, Legoix P, Lameiras S; HCC-AI study group; Bruges L, Gnemmi V, Nault JC, Campani C, Rhee H, Park YN, Iñarrairaegui M, Garcia-Porrero G, Argemi J, Sangro B, D'Alessio A, Scheiner B, Pinato DJ, Pinter M, Paradis V, Beaufrère A, Peter S, Rimassa L, Di Tommaso L, Vogel A, Michalak S, Boursier J, Loménie N, Ziol M, Calderaro J. Zeng Q, et al. Among authors: di tommaso l. Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8. Lancet Oncol. 2023. PMID: 37951222

2

Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.

Park YN, Kojiro M, Di Tommaso L, Dhillon AP, Kondo F, Nakano M, Sakamoto M, Theise ND, Roncalli M. Park YN, et al. Among authors: di tommaso l. Cancer. 2007 Mar 1;109(5):915-23. doi: 10.1002/cncr.22460. Cancer. 2007. PMID: 17279586 Free article.

3

The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.

Di Tommaso L, Destro A, Seok JY, Balladore E, Terracciano L, Sangiovanni A, Iavarone M, Colombo M, Jang JJ, Yu E, Jin SY, Morenghi E, Park YN, Roncalli M. Di Tommaso L, et al. J Hepatol. 2009 Apr;50(4):746-54. doi: 10.1016/j.jhep.2008.11.014. Epub 2008 Dec 25. J Hepatol. 2009. PMID: 19231003

4

Histopathological classification of hepatocellular carcinoma.

Roncalli M, Park YN, Di Tommaso L. Roncalli M, et al. Among authors: di tommaso l. Dig Liver Dis. 2010 Jul;42 Suppl 3:S228-34. doi: 10.1016/S1590-8658(10)60510-5. Dig Liver Dis. 2010. PMID: 20547308

5

Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis.

Iavarone M, Manini MA, Sangiovanni A, Fraquelli M, Forzenigo LV, Di Tommaso L, Aghemo A, Roncalli M, Ronchi G, Colombo M. Iavarone M, et al. Among authors: di tommaso l. Dig Liver Dis. 2013 Jan;45(1):43-9. doi: 10.1016/j.dld.2012.08.009. Epub 2012 Sep 27. Dig Liver Dis. 2013. PMID: 23022425

6

Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma.

Personeni N, Rimassa L, Pressiani T, Destro A, Ligorio C, Tronconi MC, Bozzarelli S, Carnaghi C, Di Tommaso L, Giordano L, Roncalli M, Santoro A. Personeni N, et al. Among authors: di tommaso l. J Cancer Res Clin Oncol. 2013 Jul;139(7):1179-87. doi: 10.1007/s00432-013-1429-x. Epub 2013 Apr 9. J Cancer Res Clin Oncol. 2013. PMID: 23568548

7

Advanced precancerous lesions in the liver.

Di Tommaso L, Sangiovanni A, Borzio M, Park YN, Farinati F, Roncalli M. Di Tommaso L, et al. Best Pract Res Clin Gastroenterol. 2013 Apr;27(2):269-84. doi: 10.1016/j.bpg.2013.03.015. Best Pract Res Clin Gastroenterol. 2013. PMID: 23809245 Review.

8

MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.

Vaira V, Roncalli M, Carnaghi C, Faversani A, Maggioni M, Augello C, Rimassa L, Pressiani T, Spagnuolo G, Di Tommaso L, Fagiuoli S, Rota Caremoli E, Barberis M, Labianca R, Santoro A, Bosari S. Vaira V, et al. Among authors: di tommaso l. Liver Int. 2015 Mar;35(3):1077-86. doi: 10.1111/liv.12636. Epub 2014 Jul 21. Liver Int. 2015. PMID: 25040368

9

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.

Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac-Sage P, Roncalli M, Zucman-Rossi J. Nault JC, et al. Among authors: di tommaso l. Hepatology. 2014 Dec;60(6):1983-92. doi: 10.1002/hep.27372. Epub 2014 Oct 27. Hepatology. 2014. PMID: 25123086

10

TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma.

Sciarra A, Ronot M, Di Tommaso L, Raschioni C, Castera L, Belghiti J, Bedossa P, Vilgrain V, Roncalli M, Paradis V. Sciarra A, et al. Among authors: di tommaso l. Liver Int. 2015 Nov;35(11):2466-73. doi: 10.1111/liv.12844. Epub 2015 Apr 24. Liver Int. 2015. PMID: 25865109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters